Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Cleft Palate D002972 9 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Contusions D003288 3 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Coronary Disease D003327 70 associated lipids
Coronary Thrombosis D003328 7 associated lipids
Coronary Vasospasm D003329 9 associated lipids
Cough D003371 19 associated lipids
Death, Sudden D003645 12 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Diseases in Twins D004200 4 associated lipids
Disseminated Intravascular Coagulation D004211 7 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Siess W et al. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation. 1981 Thromb. Haemost. pmid:7025338
Watanabe J et al. Effect of vitamin E on platelet aggregation in diabetes mellitus. 1984 Thromb. Haemost. pmid:6495252
Gresele P et al. Picotamide protects mice from death in a pulmonary embolism model by a mechanism independent from thromboxane suppression. 1990 Thromb. Haemost. pmid:2274931
Chen SL et al. Chlorobutanol, a preservative of desmopressin, inhibits human platelet aggregation and release in vitro. 1990 Thromb. Haemost. pmid:2096493
Cattaneo M et al. Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium. 1985 Thromb. Haemost. pmid:3927505
Perneby C et al. Dose- and time-dependent antiplatelet effects of aspirin. 2006 Thromb. Haemost. pmid:16601836
Foo LC et al. Platelets of habitual smokers have reduced susceptibility to aggregating agent. 1991 Thromb. Haemost. pmid:2048056
D'Angelo A et al. Effect of des-amino-D-arginine vasopressin (DDAVP) on plasma levels of platelet and endothelial cell release products. 1983 Thromb. Haemost. pmid:6687766
Michelson AD et al. Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. 1994 Thromb. Haemost. pmid:7522354
Hornby EJ et al. The inhibitory effect of GR32191, a thromboxane receptor blocking drug, on human platelet aggregation, adhesion and secretion. 1989 Thromb. Haemost. pmid:2529661
Halawani SH et al. Aspirin failure in patients presenting with acute cerebrovascular ischaemia. 2011 Thromb. Haemost. pmid:21544317
Cortellaro M et al. Transcoronary platelet thromboxane A2 formation without platelet trapping in patients with coronary stenosis-effect of sulphinpyrazone treatment. 1983 Thromb. Haemost. pmid:6665767
Szczeklik A et al. Prolonged bleeding time, reduced platelet aggregation, altered PAF-acether sensitivity and increased platelet mass are a trait of asthma and hay fever. 1986 Thromb. Haemost. pmid:3563961
Falcon CR et al. The in vitro production of thromboxane B2 by platelets of diabetic patients is normal at physiological concentrations of ionized calcium. 1993 Thromb. Haemost. pmid:8259535
Fruzzetti F et al. Platelet-vessel wall interactions with third-generation oral contraceptives: no evidence of detrimental effects. 1999 Thromb. Haemost. pmid:10494782
Cattaneo M et al. Conditions influencing the interaction of asialo von Willebrand factor with human platelets--the effects of external ionized calcium concentration and the role of arachidonate pathway. 1988 Thromb. Haemost. pmid:3146144
De Caterina R et al. Organic nitrates: direct antiplatelet effects and synergism with prostacyclin. Antiplatelet effects of organic nitrates. 1988 Thromb. Haemost. pmid:3291182
Teng CM and Ko FN Comparison of the platelet aggregation induced by three thrombin-like enzymes of snake venoms and thrombin. 1988 Thromb. Haemost. pmid:3291184
Davì G et al. Demonstration of Rickettsia Conorii-induced coagulative and platelet activation in vivo in patients with Mediterranean spotted fever. 1995 Thromb. Haemost. pmid:8584998
Habib A et al. Increased expression of inducible cyclooxygenase-2 in human endothelial cells by antiphospholipid antibodies. 1995 Thromb. Haemost. pmid:8585020
Pettinella C et al. Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 2009 Thromb. Haemost. pmid:19350112
Totani L et al. Prasugrel inhibits platelet-leukocyte interaction and reduces inflammatory markers in a model of endotoxic shock in the mouse. 2012 Thromb. Haemost. pmid:22436970
Spowart K et al. Haemostatic effects of ketorolac with and without concomitant heparin in normal volunteers. 1988 Thromb. Haemost. pmid:3266379
Cerletti C et al. Aspirin kinetics and inhibition of platelet thromboxane generation-relevance for a solution of the "aspirin dilemma". 1985 Thromb. Haemost. pmid:4049312
De Caterina R et al. Benefit/risk profile of combined antiplatelet therapy with ticlopidine and aspirin. 1991 Thromb. Haemost. pmid:1871711
de Boer A et al. Interaction study between Org 10172, a low molecular weight heparinoid, and acetylsalicylic acid in healthy male volunteers. 1991 Thromb. Haemost. pmid:1722918
Forastiero R et al. Anti-beta2 glycoprotein I antibodies and platelet activation in patients with antiphospholipid antibodies: association with increased excretion of platelet-derived thromboxane urinary metabolites. 1998 Thromb. Haemost. pmid:9459320
Montuschi P et al. Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD. 2005 Thorax pmid:16192367
Rodwell LT et al. Effect of inhaled frusemide and oral indomethacin on the airway response to hypertonic saline challenge in asthmatic subjects. 1997 Thorax pmid:9039247
Montuschi P et al. Exhaled leukotrienes and prostaglandins in COPD. 2003 Thorax pmid:12832671
Picado C et al. Effects of a fish oil enriched diet on aspirin intolerant asthmatic patients: a pilot study. 1988 Thorax pmid:3353894
Dapper F et al. Effects of pulsatile and nonpulsatile perfusion mode during extracorporeal circulation--a comparative clinical study. 1992 Thorac Cardiovasc Surg pmid:1290181
Zhou JA et al. The effects of dauricine and verapamil as calcium channel blockers on the plasma concentration of 6-keto-prostaglandin F1 alpha and thromboxane B2 during cardiopulmonary bypass. 1987 Thorac Cardiovasc Surg pmid:2442837
Kobinia GS et al. Influence of coronary artery obstruction on cardiac prostaglandin metabolism during experimental cardioplegic arrest. 1986 Thorac Cardiovasc Surg pmid:2424127
Pradalier A et al. [Measurement of plasma and serum values of PGE2, PGF2 alpha and TXB2 during aspirin induced bronchospasm in asthmatics (author's transl)]. 1979 Jul-Aug Therapie pmid:531778
Oelz O [The arachidonic acid metabolites (prostaglandins, thromboxanes, prostacyclin, leucotrienes):basics and clinical implications (author's transl)]. 1979 Ther Umsch pmid:119331
Morris HG et al. Effects of salsalate (nonacetylated salicylate) and aspirin on serum prostaglandins in humans. 1985 Ther Drug Monit pmid:3866409
Semenov AV et al. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension]. 2000 Ter. Arkh. pmid:10833791
Iagoda AV and Gladkikh NN [Thromboxane-prostacyclin balance and platelet aggregability in patients with minor cardiac abnormalities]. 2010 Ter. Arkh. pmid:21086621
Rud'ko IA et al. [The level of thromboxane A2 and prostacyclin in patients with chronic kidney failure undergoing hemodialysis]. 1991 Ter. Arkh. pmid:1948751
Chen YC et al. Studies of platelet hyperactivity in patients with ischemic cerebrovascular diseases: IV. Determination of the optimal dosage of aspirin by measuring plasma salicylate level. 1987 Taiwan Yi Xue Hui Za Zhi pmid:3694163
Liu MC et al. Studies of platelet hyperactivity in patients with ischemic cerebrovascular diseases. III. Platelet hyperactivation in the chronic phase of cerebral thromboembolism. 1985 Taiwan Yi Xue Hui Za Zhi pmid:3160819
Ding YA et al. Effects of exercise and ticlopidine on platelet function and prostanoids in patients with old myocardial infarction. 1989 Taiwan Yi Xue Hui Za Zhi pmid:2592938
Demling RH and Lalonde C Topical ibuprofen decreases early postburn edema. 1987 Surgery pmid:3672325
VanderMeer TJ et al. Protective effects of a novel 32-amino acid C-terminal fragment of CAP18 in endotoxemic pigs. 1995 Surgery pmid:7778029
Slotman GJ et al. Thromboxane A2 mediates hemodynamic and respiratory dysfunction in graded bacteremia. 1986 Surgery pmid:3526603
Addonizio VP et al. Prevention of heparin-induced thrombocytopenia during open heart surgery with iloprost (ZK36374). 1987 Surgery pmid:2445042
Demling RH et al. Comparison of the postburn hyperdynamic state and changes in lung function (effect of wound bacterial content). 1986 Surgery pmid:3535145
Demling RH et al. The pulmonary and systemic response to recurrent endotoxemia in the adult sheep. 1986 Surgery pmid:3535147
Kirton OC et al. The development of a model of subacute lung injury after intra-abdominal infection. 1984 Surgery pmid:6379962
Lelcuk S et al. Nicotine stimulates pulmonary parenchymal thromboxane synthesis. 1986 Surgery pmid:3775653
Cooper JD et al. Prostaglandin production associated with the pulmonary vascular response to complement activation. 1980 Surgery pmid:7394704
Nerlich M et al. Effect of thermal injury on endotoxin-induced lung injury. 1983 Surgery pmid:6337423
Huval WV et al. Thromboxane mediation of cardiovascular dysfunction following aspiration. 1983 Surgery pmid:6308843
Demling RH et al. The immediate effect of burn wound excision on pulmonary function in sheep: the role of prostanoids, oxygen radicals, and chemoattractants. 1987 Surgery pmid:3798327
Paterson IS et al. Thromboxane mediates the ischemia-induced neutrophil oxidative burst. 1989 Surgery pmid:2527418
Lelcuk S et al. Prostacyclin and thromboxane A2 moderate postischemic renal failure. 1985 Surgery pmid:3895535
Farias LR et al. Effect of prostaglandin blockers on ascites fluid in pancreatitis. 1985 Surgery pmid:3898455
Klausner JM et al. Oxygen free radicals mediate ischemia-induced lung injury. 1989 Surgery pmid:2536967
Demling RH et al. The lung inflammatory response to thermal injury: relationship between physiologic and histologic changes. 1989 Surgery pmid:2500726
Sell LL et al. Hypertension during extracorporeal membrane oxygenation: cause, effect, and management. 1987 Surgery pmid:2821641
Klausner JM et al. Interleukin-2-induced lung injury is mediated by oxygen free radicals. 1991 Surgery pmid:1899491
Goldman G et al. Leukocytes mediate acid aspiration-induced multiorgan edema. 1993 Surgery pmid:8395089
Wong C et al. Effect of hydroxyl radical scavenging on endotoxin-induced lung injury. 1985 Surgery pmid:2983450
Slotman GJ et al. Interaction of prostaglandins, activated complement, and granulocytes in clinical sepsis and hypotension. 1986 Surgery pmid:3520916
Hanazaki K et al. Protective effect of the thromboxane A2 receptor antagonist ONO 3708 on ischemia-reperfusion injury in the dog liver. 1994 Surgery pmid:7940195
Ichihara T et al. The effects of using a leukocyte removal filter during cold blood cardioplegia. 1994 Surg. Today pmid:7772907
Iwata M Pathophysiology of dogs after 84% hepatectomy with emphasis on prostaglandin metabolites and the effect of a thromboxane A2 synthesis inhibitor and a prostaglandin I2 analog. 1994 Surg. Today pmid:7780227
Isozaki H et al. The protective effect of thromboxane A2 synthetase inhibitor against ischemic liver injury. 1994 Surg. Today pmid:8054815
Isozaki H et al. Urinary thromboxane B2 as an indicator of acute rejection in human liver transplantation. 1996 Surg. Today pmid:8727944
Kitagawa M et al. The role of the spleen, especially regarding changes in both thromboxane A2 and the remnant liver dysfunction after extensive hepatectomy. 1999 Surg. Today pmid:10030738
Itasaka H et al. The mechanism of hepatic graft protection against reperfusion injury by prostaglandin E1. 1999 Surg. Today pmid:10385367
Onizuka M et al. Suppression of prostanoid formation and regulation of peripheral circulation after surgery using thrombin inhibitor (MD805). 1998 Surg. Today pmid:9681611
Yang SY and Gao ZX Determination and clinical significance of plasma levels of prostaglandins in patients with acute brain injury. 1999 Surg Neurol pmid:10511080
Seifert V et al. Arachidonic acid metabolism following aneurysm rupture. Evaluation of cerebrospinal fluid and serum concentration of 6-keto-prostaglandin F1 alpha and thromboxane B2 in patients with subarachnoid hemorrhage. 1987 Surg Neurol pmid:3810456
Kaufman RP et al. A high plasma prostaglandin to thromboxane ratio protects against renal ischemia. 1987 Surg Gynecol Obstet pmid:3672299
Ferraris VA and Swanson E Aspirin usage and perioperative blood loss in patients undergoing unexpected operations. 1983 Surg Gynecol Obstet pmid:6836459
Utsunomiya T et al. Treatment of pulmonary embolism with positive end-expiratory pressure and prostaglandin E1. 1981 Surg Gynecol Obstet pmid:7017981
Rabinovici R et al. Hemodynamic, hematologic and eicosanoid mediated mechanisms in 7.5 percent sodium chloride treatment of uncontrolled hemorrhagic shock. 1992 Surg Gynecol Obstet pmid:1411892
Mathieson MA et al. Ischemia of the limb stimulates thromboxane production and myocardial depression. 1983 Surg Gynecol Obstet pmid:6648769
Manny J et al. Pulmonary and systemic consequences of localized acid aspiration. 1986 Surg Gynecol Obstet pmid:3952619
Reines HD et al. Lack of effect of glucocorticoids upon plasma thromboxane in patients in a state of shock. 1985 Surg Gynecol Obstet pmid:3983796
Davies GC et al. Thromboxane B2 and fibrinopeptide A levels in platelet consumption and thrombosis. 1978 Surg Forum pmid:401227
Hagen AA et al. Synthesis of prostaglandins and thromboxane B2 by cerebral arteries. 1979 May-Jun Stroke pmid:462519
Heizer ML et al. 14,15-Epoxyeicosatrienoic acid inhibits platelet aggregation in mouse cerebral arterioles. 1991 Stroke pmid:1750047
Stier CT et al. Thromboxane A2 in severe hypertension and stroke in stroke-prone spontaneously hypertensive rats. 1988 Stroke pmid:3413813
Chemtob S et al. Prostanoids determine the range of cerebral blood flow autoregulation of newborn piglets. 1990 Stroke pmid:2339458
Juvela S et al. Effect of nimodipine on platelet function in patients with subarachnoid hemorrhage. 1990 Stroke pmid:2396264
Fisher M et al. Selective thromboxane inhibition: a new approach to antiplatelet therapy. 1984 Sep-Oct Stroke pmid:6474531
Jacobs TP et al. Deteriorating stroke model: histopathology, edema, and eicosanoid changes following spinal cord ischemia in rabbits. 1987 Jul-Aug Stroke pmid:3603601
Grice SC et al. Ibuprofen improves cerebral blood flow after global cerebral ischemia in dogs. 1987 Jul-Aug Stroke pmid:3603606
Nagatsuka K et al. A new approach to antithrombotic therapy--evaluation of combined therapy of thromboxane synthetase inhibitor and very low dose of aspirin. 1985 Sep-Oct Stroke pmid:3931302
Kempski O et al. Postischemic production of eicosanoids in gerbil brain. 1987 Jan-Feb Stroke pmid:3468670
van Kooten F et al. Increased platelet activation in the chronic phase after cerebral ischemia and intracerebral hemorrhage. 1999 Stroke pmid:10066850
Fujimoto T et al. Cerebrovascular injuries induced by activation of platelets in vivo. 1985 Mar-Apr Stroke pmid:3975962
van Kooten F et al. Evidence for episodic platelet activation in acute ischemic stroke. 1994 Stroke pmid:8303731
Lee TK et al. Inhibitory effect of acetylsalicylic acid on platelet function in patients with completed stroke or reversible ischemic neurologic deficit. 1988 Stroke pmid:3363589
Vinge E et al. Thromboxane B2 levels in serum during continuous administration of nimodipine to patients with aneurysmal subarachnoid hemorrhage. 1988 Stroke pmid:3363601
van Kooten F et al. Platelet activation and lipid peroxidation in patients with acute ischemic stroke. 1997 Stroke pmid:9259748
Fisher M Increased thromboxane biosynthesis in patients with acute cerebral ischemia. 1993 Stroke pmid:8506568